Our findings highlight a notable link between serum PVT1 overexpression and breast cancer, lending support to the formerly reported correlation of MYC and PVT1 co-amplification with rapid breast cancer progression and poor clinical survival in postmenopausal women with HER2positive breast cancer [46]. The gene discussed is PVT1; the disease is breast cancer.